CorriXR Therapeutics, the gene-editing cancer drug firm spun out of ChristianaCare, won the Delaware DNA pitch contest of promising startups.
The first Delaware DNA conference hosted by the Delaware BioScience Association drew about 350 people to network and listen to panels.
A new daylong conference known as “Delaware’s DNA” will showcase Delaware’s growing life science sector, expecting to draw people from across the country.
NEWARK – As life science companies have grown organically and been attracted to the First State in the past few years, it’s created a new challenge for the local labor […]
In July, more than 40 foreign ambassadors traveled from their embassy posts in Washington, D.C., to spend the day in Delaware. This was a remarkable, historic thing for our small […]
© 2023 Delaware Business Times